Lots of interesting abstracts and cases were submitted for TCTAP 2026. Below are the accepted ones after a thorough review by our official reviewers. Don¡¯t miss the opportunity to expand your knowledge!
ABS20251113_0003
Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation After David-Type Aortic Valve-Sparing Root Replacement
By Ching-Hsuan Hsu, Wei-Hsian Yin, Jeng Wei
Presenter
Ching-Hsuan Hsu
Authors
Ching-Hsuan Hsu1, Wei-Hsian Yin1, Jeng Wei1
Affiliation
Cheng Hsin General Hospital, Taiwan1
View Study Report
ABS20251113_0003
Complex TAVR
Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation After David-Type Aortic Valve-Sparing Root Replacement
Ching-Hsuan Hsu1, Wei-Hsian Yin1, Jeng Wei1
Cheng Hsin General Hospital, Taiwan1
Background
The David operation is a surgical procedurecommonly performed in patients with aortic root pathology and a normal, pliableaortic valve. During long-term follow-up, progressive degeneration of thenative valve may lead to pure aortic regurgitation (AR). Recently, the AURORAanatomical classification system and dual-anchoring concept were proposed tooptimize transcatheter aortic valve replacement (TAVR) strategies in patientswith pure AR [EuroIntervention 2025;21:952–960]. This study aimed to evaluatethe feasibility, efficacy, and safety of TAVR for pure AR after a prior Davidoperation using the AURORA classification.
Methods
Anatomical assessment was performed usingcomputed tomography to evaluate potential anchoring zones in the leftventricular outflow tract (LVOT), anatomical annulus, and ascending aorta.Based on the ability to achieve adequate theoretical anchoring (¡Ã10%oversizing) in these three zones, patients were classified into four AURORAanatomical types. The primary efficacy endpoint was device success; primarysafety endpoints included 30-day mortality and major complications.
Results
Eight patients were included: three withtype 1 anatomy, three with type 2, and two with type 4. The mean age was 59.3 ¡¾5.2 years. Device success was achieved in all type 1 patients (3/3, 100%) andin one of three type 2 patients (33%), with no procedural mortality. Both type4 patients (2/2, 100%) underwent TAVR using a dedicated J-valve, achievingcomplete device and clinical success. One case of device failure occurred inlater procedures.
Conclusion
The AURORA classification enablessystematic anatomical assessment that may facilitate favorable TAVR outcomes inselected patients with pure AR after a David operation, particularly in type 1anatomy. Given the limited anchoring strength within the Dacron graft andnative annulus/LVOT after the David procedure, dedicated transcatheter heartvalves such as the J-valve or JenaValve are strongly recommended for otheranatomical types.
